Surgical Treatment of Glaucoma

The new eyePlate-S

Same trusted plate, now with a smaller tube.

Less invasive tube insertion
Smaller lumen to limit hypotony

The eyePlate-S is pending EU regulatory approval. Contact Rheon Medical for more information on availability.

The eyeWatch

State of the art technology.

For your vision.

The eyeWatch in numbers

Published data at 1 year follow-up

IOP reduction, while
preventing hypotony

Reduction in anti-glaucoma
drugs for patients

Corneal endothelial
cell loss

IOP reduction, while
preventing hypotony

Reduction in anti-glaucoma
drugs for patients

Corneal endothelial
cell loss

S.Roy et al., Comparison Between the eyeWatch device and the Ahmed Glaucoma Valve, 2020
S.Roy et al, Initial Clinical Trial Results of the eyeWatch: a New Adjustable Glaucoma Drainage Device Used in Refractory Glaucoma Surgery, 2020.
UK clinical trial data

François, eyeWatch patient

“After numerous failed surgeries, I had an eyeWatch 2 years ago. I am finally off medications and my eye pressure has remained stable since. I am very happy with the results as I never had the need for a re-operation. “

Dr. Ike Ahmed

“Titration is the holy grail for glaucoma surgery, to provide an ability to adjust flow for individual patient needs at specific postoperative time points. The eyeWatch glaucoma shunt is a major step forward in protecting from early hypotony while allowing for added IOP reduction as needed. “